Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
12

Summary

Conditions
Multiple Myeloma
Type
Interventional
Phase
Phase 1
Design
Allocation: Non-RandomizedIntervention Model: Single Group AssignmentIntervention Model Description: This study has 3+3 dose escalation design.Masking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04177823
Collaborators
Not Provided
Investigators
Study Director: GSK Clinical Trials GlaxoSmithKline